4th Quarter - Report
TIBER CREEK HEALTH STRATEGIES, INC. for GENENTECH, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRYANT HALL | — |
Health Issues HCR
Issues related to 340b drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRYANT HALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.